Tagged as: Association for Accessible Medicines (AAM)

Generic and Biosimilar Drugs Save $408B For America’s Patients and Healthcare System in 2022

On September 6, 2023, the Association for Accessible Medicines (AAM) released its 2023 U.S. Generic & Biosimilar Medicines Savings Report highlighting the significant economic contributions of generic and biosimilar medicines.  Notably, the U.S. healthcare system, including patients, employers and taxpayers, saved $408 billion in 2022 by using FDA-approved generic and…

Read More